ISOLPHARM at SMRD2: the future of theragnostics

The European Federation of the Organizations of Medical Physics (EFOMP), through its Special Interest Group For Radionuclide Internal Dosimetry (SIG_FRID), after the great success of the 1st edition in 2023, organized the 2nd Symposium on Molecular Radiotherapy Dosimetry in Athens, Greece from 13th to 15th November 2025. This congress, subtitled “The future of theragnostics”, was in fact aimed at shaping the future of this field within its clinical applications.

ISOLPHARM was represented by Alberto Arzenton’s talk “Computed dosimetry for the preclinical assessment of silver-111 in the context of the ISOLPHARM project”, putting silver-111 in the panorama of the most interesting candidates for targeted radionuclide therapy in the coming years. The presentation is available on the “Documents” section of the website.